Back

Implanted cardioverter defibrillator (ICD) therapy in patients with suspected myocarditis: time of implantation and occurrence of ventricular arrhythmias

19 June 2017 (11:10 - 11:20)
Organised by:
Congress Presentation Part of: Rapid Fire session 1 - ICD and prevention of sudden death Primary prevention (Sudden cardiac death and implantable defibrillators) EHRA Premium Access EHRA EUROPACE - CARDIOSTIM 2017

About the speaker

Photo
Doctor Valerie Pavlicek

Saarland University Hospital, Homburg (Germany)

7 More presentations in this session

Presentation thumbnail
Reappraisal of the value of electrophysiological study in sudden cardiac death risk stratification in hypertrophic cardiomyopathy
Associate Professor K. Gatzoulis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Six year follow-up of the initial dutch subcutaneous implantable cardioverter-defibrillator cohort: Long term complications and battery longevity.
Ms A. Quast (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Long-term follow-up of elderly implantable cardioverter-defibrillator patients
Ms D. Yilmaz (Leiden, NL)
Abstract Slides Video
Presentation thumbnail
A comparison of clinical outcomes of subcutaneous and transvenous implantable defibrillator therapy in the SIMPLE and EFFORTLESS studies
Doctor T. Brouwer (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Scar characterization to predict life-threateninG Arrhythmic events and sudden cardiac death in cardiac resynchronization therapy patients. The GAUDI-CRT study.
Doctor J. Acosta Martinez (Seville, ES)
Abstract

Access the full session

Session thumbnail
Rapid Fire session 1 - ICD and prevention of sudden death

The Event

Event poster

EHRA EUROPACE - CARDIOSTIM 2017

19 June 2017 11:10 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources